Skip to main content
Caplight Logo









Ainnova Tech

Ainnova Tech

Private
Houston, TexasHealthcare & Life Scienceshttps://ainnovatech.com/

Last Round

Accelerator

Feb 22, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ainnova Tech is a health tech company that provides an artificial intelligence-based platform, VisionAi, for the early detection of diseases such as diabetic retinopathy.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

medical AIretinal imagingdiabetic retinopathy screeningAI diagnosticsmedtechhealthtechmedical imaging softwareAI-powered diagnosticsclinical decision supportusage-based SaaSprimary care technologyfundus imagingAI healthcaredigital healthmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ainnova Tech Comparables

Compare Ainnova Tech with similar companies based on industry and business-model similarity.

Ainnova Tech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RETINA-AI Health
94%
MONA Health
89%
Optain Health
88%

Ainnova Tech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 22, 2024
AcceleratorMar 29, 2023

Key People

Founding team and executive leadership

Vinicio Vargas

Co-founder CEO

Founding Team

Rodrigo Herrera G

Chief Technology Officer

Executive Team

Ainnova Tech Investors

Notable investors and investment history

Ainnova Tech investors
InvestorRounds
AsiarathAccelerator
Fuel AcceleratorAccelerator
Dubai Future FoundationAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Monthly visitors grew 143% MoM, reaching 1.6K.

  • Oct 22, 2025

    Acquired OTCHealth Inc. as part of a strategic alliance.

Ainnova Tech Filings

Explore SEC and related filing metadata, where available.

Ainnova Tech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ainnova Tech's valuation, stock price, and market status.

Is Ainnova Tech a public or private company?

Ainnova Tech is a private company.

What is the current stock price of Ainnova Tech?

Ainnova Tech is a private company with no public stock price. No recent secondary market data is available.

How much is Ainnova Tech worth (valuation)?

Valuation information for Ainnova Tech is not publicly available.

Can I buy Ainnova Tech stock?

Ainnova Tech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ainnova Tech's last funding round?

Ainnova Tech's most recent funding round was Accelerator on February 22, 2024.

Who are the main investors in Ainnova Tech?

Key investors in Ainnova Tech include Asiarath, Dubai Future Foundation.

Will Ainnova Tech IPO soon?

No public IPO plans have been announced for Ainnova Tech.

How can I track Ainnova Tech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ainnova Tech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Employee Range10
Year Founded2020
Last FundingFeb 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?